Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims
RICHMOND, Va., Aug. 21, 2023 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the "Company"), has reached an agreement ("Agreement") to resolve the claims brought by the end payor class of litigants ("the End Payor Claimants") in the In re Suboxone Antitrust Litigation multi-district litigation ("MDL").
- RICHMOND, Va., Aug. 21, 2023 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the "Company"), has reached an agreement ("Agreement") to resolve the claims brought by the end payor class of litigants ("the End Payor Claimants") in the In re Suboxone Antitrust Litigation multi-district litigation ("MDL").
- The Agreement marks the resolution of the End Payor Claimants' claims against the Company in the MDL.
- As part of the Agreement, the Company expects to pay $30 million to the End Payor Claimants.
- Once the Agreement is approved and entered by the Court, the final settlement amount will be recorded against the $188 million provision.